PO70 | Clinical safety and monitoring of apixaban combined with tacrolimus and everolimus in kidney transplant patients: a prospective study
Background and Aims: The use of direct oral anticoagulants (DOACs) in kidney transplant recipients presents a clinical challenge due to potential drug–drug interactions with immunosuppressive agents, particularly tacrolimus and everolimus. Data on the safety and efficacy of DOACs in this population...
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
PAGEPress Publications
2025-08-01
|
| Series: | Bleeding, Thrombosis and Vascular Biology |
| Subjects: | |
| Online Access: | https://www.btvb.org/btvb/article/view/339 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PO89 | Apixaban for secondary prevention of venous thromboembolism in hemodialysis patients: pharmacokinetic profile and safety outcomes
Published: (2025-08-01) -
PO53 | Effectiveness and safety of DOACS in patients with renal transplantation
Published: (2025-08-01) -
PO93 | Use of DOACS in heart transplantation recipients
Published: (2025-08-01) -
PO07 | Liver transplant in a case of congenital afibrinogenemia
Published: (2025-08-01) -
PO08 | Efficacy and safety of thromboprophylaxis in hospitalized hematological patients: a monocenter retrospective study
Published: (2025-08-01)